hotspot -WSS

hotspot

author：hotspot 2025-10-02 15:43:33 - browse：21768

Anna Yeo/STAT

Recently approved gene therapies offer patients one-time, potentially curative treatments for genetic diseases such as sickle cell anemia and beta thalassemia. But “one-time” miracle solutions can often be multi-month affairs, require millions of dollars, and cause painful side effects. What if that doesn’t have to be the case?

In utero gene editing, or prenatal somatic cell genome editing, envisions treating a fetus diagnosed with a genetic disease before birth, thereby preventing that entire protocol and the onset of symptoms in the first place. It would also challenge the need for the ethically fraught enterprise of embryo editing, as the treatment would only make edits in the DNA of the individual fetus — edits which would not be passed on in a heritable way.

Watch this video to learn more about in utero gene editing, how it works, and why scientists believe it might be an advantageous approach to treating certain genetic diseases.

Previous article： Guidelines to prevent youth baseball injuries need more muscle
Next article： Industry veterans launch new biotech VC with $310M

WSS

Change Healthcare outage fallout shows need for new oversight

To avoid data mishandling cases, universities eye AI and other tools

Amylyx ALS drug fails trial: Relyvrio patients react with fear, worry

Private equity deals in Medicare Advantage declines

What we’ve learned from the Aduhelm mess

Amid AI frenzy, a top HHS official's quest to create safeguards

explore

hotspot

focus

Psychedelics group wrestles with new pharma identity

RaDonda Vaught links Vanderbilt hospital issues to patient death

In age of alternative facts, a scholarly course on calling out crap

Ebola: Gilead Sciences antiviral shows promise as new treatment

Alkermes shareholders re

John Green on his newest strategy for fighting tuberculosis

United colonoscopy coverage change 'may cost lives,' doctors say

What we’ve learned from the Aduhelm mess

Apple is now the first public company to be valued at $3 trillion

First U.S. drug developed to treat liver disease MASH is approved

Wikipedia

Robert F. Kennedy is pitching centrism on health, even on abortion

A ‘polypill’ could sharply reduce cardiovascular disease in the U.S.

EPA limits use of carcinogenic gas for sterilizing medical devices

Biden report: The neurospychology of memory and aging

As AI in medicine takes off, can 'human in the loop' prevent harm?

Gilead might be held responsible for not developing a drug

focus

Wikipedia

Wikipedia

hotspot